SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BICO & VITK
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Terry D. who wrote (1801)7/9/1998 12:45:00 AM
From: Tom R. Jones  Read Replies (1) of 2395
 
Terry, I agree with you. I am surprised that BICO hasn't issued a PR about the effectiveness of the diasensor. I've seen other companies do that.

BTW, I found this on Edgar:

<< During the three months ended March 31, 1998, the Company
issued 4% Subordinate Convertible Debentures totaling
$5,220,000 to entities which are not a U.S. person as that
term is defined in Rule 902(O) of Regulation S and were not
saleable or convertible for a minimum of 45 days from issuance
(See "Management's Discussion and Analysis").>>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News